{"id":"https://openalex.org/W4385197230","doi":"https://doi.org/10.1136/jitc-2023-007309","title":"Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development","display_name":"Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development","publication_year":2023,"publication_date":"2023-07-01","ids":{"openalex":"https://openalex.org/W4385197230","doi":"https://doi.org/10.1136/jitc-2023-007309","pmid":"https://pubmed.ncbi.nlm.nih.gov/37487665","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10373737"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-007309","doi":"https://doi.org/10.1136/jitc-2023-007309","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-007309","pdf_url":"https://jitc.bmj.com/content/jitc/11/7/e007309.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/7/e007309.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000768609","display_name":"Hussein A. Tawbi","orcid":"https://orcid.org/0000-0003-1942-851X","observed_orcids":["https://orcid.org/0000-0003-1942-851X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hussein A Tawbi","raw_affiliation_strings":["Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA"],"raw_orcid":"https://orcid.org/0000-0003-1942-851X","affiliations":[{"raw_affiliation_string":"Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ryan J Sullivan","raw_affiliation_strings":["Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA","Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0001-5344-6645","affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084822027","display_name":"David Feltquate","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Feltquate","raw_affiliation_strings":["Palleon Pharmaceuticals Inc, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Palleon Pharmaceuticals Inc, Waltham, Massachusetts, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066301151","display_name":"Theresa M. LaVallee","orcid":"https://orcid.org/0000-0002-1769-3195","observed_orcids":["https://orcid.org/0000-0002-1769-3195"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theresa LaVallee","raw_affiliation_strings":["Coherus Biosciences, Redwood City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coherus Biosciences, Redwood City, California, USA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075877134","display_name":"Naiyer A. Rizvi","orcid":"https://orcid.org/0000-0002-1134-7494","observed_orcids":["https://orcid.org/0000-0002-1134-7494"]},"institutions":[{"id":"https://openalex.org/I4387152537","display_name":"Synthekine","ror":"https://ror.org/01j84fh13","country_code":"US","type":"company","lineage":["https://openalex.org/I4387152537"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naiyer A Rizvi","raw_affiliation_strings":["Synthekine, Menlo Park, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synthekine, Menlo Park, California, USA","institution_ids":["https://openalex.org/I4387152537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022594161","display_name":"Elad Sharon","orcid":"https://orcid.org/0000-0002-0044-9719","observed_orcids":["https://orcid.org/0000-0002-0044-9719"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elad Sharon","raw_affiliation_strings":["Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":"https://orcid.org/0000-0002-0044-9719","affiliations":[{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075566772","display_name":"Jeffrey Alan Sosman","orcid":"https://orcid.org/0000-0002-0650-9698","observed_orcids":["https://orcid.org/0000-0002-0650-9698"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Sosman","raw_affiliation_strings":["Department of Hematology and Oncology, Northwestern University, Evanston, Illinois, USA","Jeff Sosman, Northwestern University, Chicago, Illinois, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Northwestern University, Evanston, Illinois, USA","institution_ids":["https://openalex.org/I111979921"]},{"raw_affiliation_string":"Jeff Sosman, Northwestern University, Chicago, Illinois, USA","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001175430","display_name":"Harriet M. Kluger","orcid":"https://orcid.org/0000-0002-4932-9873","observed_orcids":["https://orcid.org/0000-0002-4932-9873"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harriet M Kluger","raw_affiliation_strings":["Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA"],"raw_orcid":"https://orcid.org/0000-0002-4932-9873","affiliations":[{"raw_affiliation_string":"Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5008479799"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":1.457,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.83115719,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"11","issue":"7","first_page":"e007309","last_page":"e007309"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1-pd-l1-inhibitors","display_name":"PD-1/PD-L1 inhibitors","score":0.8619999885559082},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.9120000004768372},{"id":"https://openalex.org/keywords/primary-resistance","display_name":"primary resistance","score":0.925000011920929},{"id":"https://openalex.org/keywords/secondary-resistance","display_name":"secondary resistance","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-emergent-resistance","display_name":"treatment-emergent resistance","score":0.5680000185966492},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.8190000057220459},{"id":"https://openalex.org/keywords/terminology-harmonization","display_name":"terminology harmonization","score":0.7919999957084656},{"id":"https://openalex.org/keywords/data-sharing","display_name":"data sharing","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C547195049","wikidata":"https://www.wikidata.org/wiki/Q1725664","display_name":"Terminology","level":2,"score":0.6429436206817627},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.612464964389801},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6020005941390991},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.5189175605773926},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5068753361701965},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5063658952713013},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4884006381034851},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4758296310901642},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3973429203033447},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.39225679636001587},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36039209365844727},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.324840247631073},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2833586633205414},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09505316615104675},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008495","descriptor_name":"Medical Oncology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1136/jitc-2023-007309","doi":"https://doi.org/10.1136/jitc-2023-007309","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-007309","pdf_url":"https://jitc.bmj.com/content/jitc/11/7/e007309.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10373737","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10373737","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10373737/pdf/jitc-2023-007309.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:37487665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37487665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b4ec42c072fc44199e543822100f2358","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b4ec42c072fc44199e543822100f2358","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-007309","doi":"https://doi.org/10.1136/jitc-2023-007309","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-007309","pdf_url":"https://jitc.bmj.com/content/jitc/11/7/e007309.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000905448","display_name":"Yale Clinical and Translational Science Award","funder_award_id":"UL1TR001863","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320312902","display_name":"Society for Immunotherapy of Cancer","ror":"https://ror.org/0481e3r23"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385197230.pdf","grobid_xml":"https://content.openalex.org/works/W4385197230.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W2996316560","https://openalex.org/W3014748351","https://openalex.org/W3047740167","https://openalex.org/W3095965358","https://openalex.org/W4220699978","https://openalex.org/W4234912275","https://openalex.org/W4324139608","https://openalex.org/W4324139686","https://openalex.org/W4324195767"],"related_works":["https://openalex.org/W3014748351","https://openalex.org/W4324195767","https://openalex.org/W4410810625","https://openalex.org/W4324139608","https://openalex.org/W3214299987","https://openalex.org/W4324139686","https://openalex.org/W4298008712","https://openalex.org/W4388661332","https://openalex.org/W2981341506","https://openalex.org/W4400892363"],"abstract_inverted_index":{"The":[0],"need":[1],"for":[2,17,29,40,50],"solid":[3],"clinical":[4,18],"definitions":[5,39,61,83],"of":[6,31,59,81],"resistance":[7,44,46],"to":[8,97],"programmed":[9],"death":[10],"1":[11],"or":[12],"its":[13],"ligand":[14],"(PD-(L)1)":[15],"inhibitors":[16,54],"trial":[19],"design":[20],"was":[21],"identified":[22],"as":[23],"a":[24],"priority":[25],"by":[26],"the":[27,86,90,93],"Society":[28],"Immunotherapy":[30],"Cancer":[32],"(SITC).":[33],"Broad":[34],"consensus":[35],"efforts":[36],"have":[37],"provided":[38],"primary":[41],"and":[42,45,55,64,69,79,84,92],"secondary":[43],"after":[47],"stopping":[48],"therapy":[49],"both":[51,89],"single-agent":[52],"PD-(L)1":[53],"associated":[56],"combinations.":[57],"Validation":[58],"SITC's":[60,82],"is":[62],"critical":[63],"requires":[65],"field-wide":[66],"data":[67],"sharing":[68],"collaboration.":[70],"Here,":[71],"in":[72],"this":[73],"commentary,":[74],"we":[75],"detail":[76],"current":[77],"utility":[78],"incorporation":[80],"discuss":[85],"next":[87],"steps":[88],"society":[91],"field":[94],"must":[95],"take":[96],"further":[98],"advance":[99],"immuno-oncology":[100],"drug":[101],"development.":[102]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-07-25T00:00:00"}